The PE Ratio as of December 2024 (TTM) for Jasper Therapeutics, Inc. (JSPR) is -4.57

According to Jasper Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.57. This represents a change of 2.03% compared to the average of -4.48 of the last 4 quarters.

Jasper Therapeutics, Inc. (JSPR) Historical PE Ratio (quarterly & annually)

How has JSPR PE Ratio performed in the past?

The mean historical PE Ratio of Jasper Therapeutics, Inc. over the last ten years is -1.32. The current -4.57 PE Ratio has changed 34.46% with respect to the historical average. Over the past ten years (40 quarters), JSPR's PE Ratio was at its highest in in the March 2022 quarter at 38.53. The PE Ratio was at its lowest in in the June 2021 quarter at -111.69.

Jasper Therapeutics, Inc. (JSPR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Jasper Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jasper Therapeutics, Inc. (JSPR) Average PE Ratio

How has JSPR PE Ratio performed in the past?

The current PE Ratio of Jasper Therapeutics, Inc. (JSPR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Jasper Therapeutics, Inc. (JSPR) PE Ratio vs. Peers

How is JSPR’s PE Ratio compared to its peers?

Jasper Therapeutics, Inc.’s PE Ratio is less than Lyra Therapeutics, Inc. (-0.12), greater than Equillium, Inc. (-4.96), less than HOOKIPA Pharma Inc. (-0.55), less than LianBio (-0.75), less than Acumen Pharmaceuticals, Inc. (-1.32), less than Galera Therapeutics, Inc. (-0.08), less than Inozyme Pharma, Inc. (-1.92), less than Eledon Pharmaceuticals, Inc. (18.27), greater than Icosavax, Inc. (-15.78), greater than Edgewise Therapeutics, Inc. (-22.36), less than Ikena Oncology, Inc. (-1.24), greater than Design Therapeutics, Inc. (-7.53), less than Xilio Therapeutics, Inc. (-1.16), less than Eliem Therapeutics, Inc. (0), less than POINT Biopharma Global Inc. (0), greater than ORIC Pharmaceuticals, Inc. (-26.34), greater than Inhibrx Biosciences, Inc. (-4.82), less than ESSA Pharma Inc. (0.14), less than null (-2.50),

Build a custom stock screener for Jasper Therapeutics, Inc. (JSPR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jasper Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jasper Therapeutics, Inc. (JSPR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jasper Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.